Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: A population-based study

Annals of Oncology

Volumn 24, Issue 1, 2013, Pages 202-208

  Youn, P ^a   Li, H ^b   Milano, M T ^a   Stovall, M ^c   Constine, L S ^a   Travis, L B ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer survivorship; Gastrointestinal cancers; Hodgkin lymphoma; Second cancers; SEER

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; POPULATION BASED CASE CONTROL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME;

AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 84871580971     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds218     Document Type: Article

References (32)

1. Donaldson SS, Hancock SL, Hoppe RT. The Janeway lecture. Hodgkin's disease-finding the balance between cure and late effects. Cancer J Sci Am 1999; 5: 325-333.
2. Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al. Long-term causespecific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003; 21: 3431-3439.
3. Hoppe RT. Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol 1997; 8: 115-118.
4. Mauch PM, Kalish LA, Marcus KC et al. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1995; 1: 33-42.
5. Ng AK, Bernardo MV, Weller E et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002; 100: 1989-1996.
6. Hodgson DC, Gilbert ES, Dores GM et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 2007; 25: 1489-1497.
7. Dores GM, Metayer C, Curtis RE et al. Second malignant neoplasms among longterm survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002; 20: 3484-3494.
8. van Leeuwen FE, Klokman WJ, Veer MB et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000; 18: 487-497.
9. Swerdlow AJ, Barber JA, Hudson GV et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18: 498-509.
10. Behringer K, Josting A, Schiller P et al. Solid tumors in patients for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group. Ann Oncol 2004; 15: 1079-1085.
11. Milano MT, Li H, Gail MH et al. Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. J Clin Oncol 2010; 28: 5088-5096.
12. Birdwell SH, Hancock SL, Varghese A et al. Gastrointestinal cancer after treatment of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997; 17: 67-73.
13. Surveillance, Epidemiology, and End Results (SEER) Program: SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, November 2009 Sub (1973-2007) (Katrina/Rita Population Adjustment). Linked To County Attributes: Total US, 1969-2007 Counties. (National Cancer Institute, Division of Cancer Control and Population Sciences, Bethesda, MD) Surveillance Research Program, Cancer Statistics Branch, (April 2010, date last released), based on the November 2009 submission; www.seer.cancer.gov.
14. Milano MT, Li H, Constine LS, Travis LB. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients. Cancer 2011; 117: 5538-5547.
15. SAS Institute Inc., SAS 9.1.3 Help and Documentation, Cary, NC: SAS Institute INC., 2000-2004.
16. Stovall M, Weathers R, Kasper C et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res 2006; 166: 141-157.
17. van den Belt-dusebout AW, Aleman BM, Besseling G et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 2009; 75: 1420-1429.
18. Ng AK, Bernardo MP, Weller E et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20: 2101-2108.
19. Elkin EB, Klem ML, Gonzales AM et al. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. J Clin Oncol 2011; 29: 2466-2473
20. Lee PY, Fletcher WS, Sullivan ES et al Colorectal cancer in young patients: characteristics and outcome. Am Surg 1994; 60: 607-612.
21. Leff DR, Chen A, Roberts D et al. Colorectal cancer in the young patient. Am Surg 2007; 73: 42-47.
22. Griffin PM, Liff JM, Greenberg RS et al. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology 1991; 100: 1033-1041.
23. Liang JT, Huang KC, Cheng AL et al. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg 2003; 90: 205-214.
24. O'Connell JB, Maggard MA, Liu JH et al. Do young colon cancer patients have worse outcomes? World J Surg 2004; 28: 558-562.
25. Haugstvedt TK, Viste A, Eide GE et al. Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial. Br J Surg 1993; 80: 475-488.
26. Winslet MC., Mohsen YM, Powell J et al. The influence of age on the surgical management of carcinoma of the stomach. Eur J Surg Oncol 1996; 22: 220-224.
27. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
28. Leung WK, Wu M, Kakugawa Y, and the Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-287.
29. Sasazuki S, Sasaki S, Tsugane S, and Japan Public Health Center Study Group. Cigarette smoking, alcohol consumption, and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 2002; 101: 560-566.
30. Hisamichi S. Screening for gastric cancer. World J Surg 1989; 13: 31-37.
31. Fukao A, Tsubono Y, Tsuji I et al. The evaluation of screening for gastric cancer in Miyagi prefecture, Japan. A population-based case-control study. Int J Cancer 1995; 60: 45-48.
32. Kunisaki C, Ishino J, Nakajima S et al. Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol 2006; 13: 221-228.